Moderna data shows mRNA isn’t a quick fix for the flu vaccine
The first data from clinical trials of Moderna’s mRNA-based seasonal flu vaccine, released by the company Friday morning, were underwhelming
Influenza
Clinical trials for ‘entirely new’ mRNA flu vaccines launching soon. Will they work better?
Based on COVID-19 ‘messenger’ RNA or mRNA vaccines, the new flu vaccines could better protect people from multiple types of...
Flu Season Is Coming. mRNA Flu Shots Aren’t Far Behind
Both Moderna and Pfizer—makers of the first vaccines to earn U.S. Food and Drug Administration (FDA) approval using the mRNA technology—are studying...
